for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Updated

BRIEF-Panacea Biotec Says U.S. FDA Accepts Co's Marketing Application For Generic Cancer Drug

By Reuters Staff

Nov 30 (Reuters) - Panacea Biotec Ltd:

* SAYS U.S. FDA ACCEPTS CO'S ANDA FOR PACLITAXEL PROTEIN BOUND PARTICLES Source text: bit.ly/2BnVN02 Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up